AMP-dNM treatment restores insulin sensitivity in ob/ob mice (16) and also inhibits atherosclerosis in APOE*3 Leiden as well as low-density lipoprotein receptor−/− mice (29). The gene discussed is APOE; the disease is atherosclerosis.